DrugPatentWatch Database Preview
ACTEMRA Drug Profile
Email this page to a colleague
» See Plans and PricingSummary for Tradename: ACTEMRA
| Patents: | 70 |
| Applicants: | 1 |
| BLAs: | 2 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for ACTEMRA |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ACTEMRA |
Recent Clinical Trials for ACTEMRA
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Bristol-Myers Squibb | Phase 1/Phase 2 |
| Incyte Corporation | Phase 1 |
| Clinical Trials in Organ Transplantation | Phase 1/Phase 2 |
Recent Litigation for ACTEMRA
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Celgene Corporation v. Aurobindo Pharma Limited | 2018-07-06 |
| CELGENE CORPORATION v. EMCURE PHARMACEUTICALS LTD. | 2018-06-28 |
| CELGENE CORPORATION v. SANDOZ INC. | 2018-06-26 |
PTAB Litigation
| Petitioner | Date |
|---|---|
| 2017-04-12 |
Pharmacology for ACTEMRA
| Mechanism of Action | Interleukin 6 Receptor Antagonists |
Patent Text Search: US Patents for ACTEMRA
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | ACTEMRA | tocilizumab | INJECTABLE; INJECTION | 125276 | 001 | 2010-01-08 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Genentech | ACTEMRA | tocilizumab | INJECTABLE; INJECTION | 125276 | 001 | 2010-01-08 | Start Trial | OXFORD UNIVERSITY INNOVATION LIMITED (Oxford, GB) | 2034-01-13 | RX | search | |
| Genentech | ACTEMRA | tocilizumab | INJECTABLE; INJECTION | 125276 | 001 | 2010-01-08 | Start Trial | 2039-02-26 | RX | search | ||
| Genentech | ACTEMRA | tocilizumab | INJECTABLE; INJECTION | 125276 | 001 | 2010-01-08 | Start Trial | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for ACTEMRA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 5711751 | Start Trial |
| Japan | 2016513712 | Start Trial |
| Australia | 6761098 | Start Trial |
| Canada | 2862476 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
